Drug comparisons
Repaglinide vs Miglitol
Compare Repaglinide and Miglitol for type 2 diabetes: mechanisms, hypoglycemia risk, GI effects, and mealtime use. See which oral antidiabetic may suit your needs.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting an oral mealtime agent for type 2 diabetes after metformin, weighing insulin secretagogue vs alpha-glucosidase inhibitor options.
Bottom line
Repaglinide may offer stronger postprandial glucose lowering via insulin release, while Miglitol provides a non-insulin, GI-focused alternative with lower hypoglycemia risk when used alone.
All medication comparisons